S. No. | Title and Authors Name |
---|---|
1 |
Benzene-mediated hepato-toxicity: A review of the underlying mechanisms
Subhankar Paul and Priyankar Pal
Int. J. Hepatol. Res., 2024; 6(1): 01-03
|
2 |
Combating liver disease through comprehensive alcohol control
Dr. Lars Andersen, Dr. Erik Haugland and Magnus Nilsen
Int. J. Hepatol. Res., 2024; 6(1): 04-10
|
3 |
A cross-sectional study on the variability of Pediatric fatty liver disease diagnosis
Dr. Emily Taylor
Int. J. Hepatol. Res., 2024; 6(1): 11-14
|
4 |
Assessing the cost-effectiveness of integrating hepatitis B and C screening in routine healthcare practices
Dr. Patrick Byrne and Dr. Liam Maeve
Int. J. Hepatol. Res., 2024; 6(1): 15-17
|
5 |
Evaluating treatment outcomes in patients with acute-on-chronic liver failure
Fatima Abdel-Rahman and Dr. Ahmed Youssef
Int. J. Hepatol. Res., 2024; 6(1): 18-20
|
6 |
Impact of antiviral therapy on long-term outcomes in chronic hepatitis B patients
Dr. Carolina RodrÃguez and Pablo Martinez
Int. J. Hepatol. Res., 2024; 6(1): 21-24
|
7 |
Hepatomegaly as a predictor of disease progression in acute myeloid Leukemia Patients
Dr. Anna Lewandowska and Dr. Magdalena Zielinska
Int. J. Hepatol. Res., 2024; 6(1): 25-27
|
8 |
The role of uric acid in Cardiometabolic Health
Dr. Matteo Martelli and Dr. Lorenzo Moretti
Int. J. Hepatol. Res., 2024; 6(1): 28-31
|
9 |
Role of hepatobiliary transporters in the assembly of biliary lipids in native bile formation
Dr. Themba Dlamini
Int. J. Hepatol. Res., 2024; 6(1): 32-34
|
10 |
Racial and Ethnic disparities in primary liver cancer: Causes and Consequences
Dr. Sarah Baker and David Collins
Int. J. Hepatol. Res., 2024; 6(1): 35-37
|